{"id":"https://openalex.org/W4200370560","doi":"https://doi.org/10.1016/j.annonc.2021.10.109","title":"91P Phase I dose escalation of IMC-C103C, a CD3\u00d7MAGE-A4 T-cell receptor (TCR) bispecific protein","display_name":"91P Phase I dose escalation of IMC-C103C, a CD3\u00d7MAGE-A4 T-cell receptor (TCR) bispecific protein","publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200370560","doi":"https://doi.org/10.1016/j.annonc.2021.10.109"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.10.109","doi":"https://doi.org/10.1016/j.annonc.2021.10.109","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.109","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2021.10.109","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030169825","display_name":"Diwakar Davar","orcid":"https://orcid.org/0000-0002-7846-8055","observed_orcids":["https://orcid.org/0000-0002-7846-8055"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Davar","raw_affiliation_strings":["UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073289880","display_name":"Randy F. Sweis","orcid":"https://orcid.org/0000-0002-0497-9637","observed_orcids":["https://orcid.org/0000-0002-0497-9637"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.F. Sweis","raw_affiliation_strings":["UChicago Medicine, University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UChicago Medicine, University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210087865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057109001","display_name":"George Blumenschein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Blumenschein","raw_affiliation_strings":["Department of Thoracic-Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic-Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112841365","display_name":"Rodolfo Gutierrez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104507","display_name":"Angeles Clinic and Research Institute","ror":"https://ror.org/01ct2ab72","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834","https://openalex.org/I4210104507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Gutierrez","raw_affiliation_strings":["Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210104507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029243551","display_name":"Ignacio Melero","orcid":"https://orcid.org/0000-0002-1360-348X","observed_orcids":["https://orcid.org/0000-0002-1360-348X"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"I. Melero","raw_affiliation_strings":["Laboratory of Immunology, Clinica Universitaria de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Immunology, Clinica Universitaria de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071069834","display_name":"H.A. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H.A. Chen","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University of California Davis Comprehenvise Cancer Center, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of California Davis Comprehenvise Cancer Center, Sacramento, CA, USA","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020696914","display_name":"Fiona C. Thistlethwaite","orcid":"https://orcid.org/0000-0002-4832-7008","observed_orcids":["https://orcid.org/0000-0002-4832-7008"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F. Thistlethwaite","raw_affiliation_strings":["Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069337573","display_name":"Kathleen N. Moore","orcid":"https://orcid.org/0000-0002-5803-0718","observed_orcids":["https://orcid.org/0000-0002-5803-0718"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]},{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K.N. Moore","raw_affiliation_strings":["Department of Obstetrics and Gynecology University, Stephenson Cancer Center/University of Oklahoma, Oklahoma City, OK, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology University, Stephenson Cancer Center/University of Oklahoma, Oklahoma City, OK, USA","institution_ids":["https://openalex.org/I4390039380","https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062202820","display_name":"Neil Howard Segal","orcid":"https://orcid.org/0000-0002-3047-2303","observed_orcids":["https://orcid.org/0000-0002-3047-2303"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N.H. Segal","raw_affiliation_strings":["Division of Gastrointestinal Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gastrointestinal Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059711568","display_name":"Elena Garralda","orcid":"https://orcid.org/0000-0002-4412-7842","observed_orcids":["https://orcid.org/0000-0002-4412-7842"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Garralda","raw_affiliation_strings":["Early Drug Development Group, Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Group, Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004799762","display_name":"Breelyn Ann Wilky","orcid":"https://orcid.org/0000-0001-5080-497X","observed_orcids":["https://orcid.org/0000-0001-5080-497X"]},"institutions":[{"id":"https://openalex.org/I4210087413","display_name":"University of Colorado Health","ror":"https://ror.org/0107w4315","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087413"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Wilky","raw_affiliation_strings":["Cancer Center - PPDS, UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center - PPDS, UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora, CO, USA","institution_ids":["https://openalex.org/I4210087413","https://openalex.org/I4210134151","https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012989377","display_name":"Hendrik\u2010Tobias Arkenau","orcid":"https://orcid.org/0000-0002-2015-1549","observed_orcids":["https://orcid.org/0000-0002-2015-1549","https://orcid.org/0000-0003-0372-0540"]},"institutions":[{"id":"https://openalex.org/I172427033","display_name":"Sarah Cannon Research Institute","ror":"https://ror.org/03cp5cj42","country_code":"GB","type":"education","lineage":["https://openalex.org/I172427033"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H-T. Arkenau","raw_affiliation_strings":["SCRI, Sarah Cannon Research Institute SCRI UK, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCRI, Sarah Cannon Research Institute SCRI UK, London, UK","institution_ids":["https://openalex.org/I172427033"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038656790","display_name":"Thomas R. Jeffry Evans","orcid":"https://orcid.org/0000-0002-4175-914X","observed_orcids":["https://orcid.org/0000-0002-4175-914X"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T.R.J. Evans","raw_affiliation_strings":["Institute of Cancer Sciences, University of Glasgow, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Sciences, University of Glasgow, Glasgow, UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049294543","display_name":"Melissa Lynne Johnson","orcid":"https://orcid.org/0000-0001-9874-1314","observed_orcids":["https://orcid.org/0000-0001-9874-1314"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.L. Johnson","raw_affiliation_strings":["Medical Oncology Department, Sarah Cannon Research Institute-Cancer Centre, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Sarah Cannon Research Institute-Cancer Centre, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110684921","display_name":"Mohammed M. Dar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Dar","raw_affiliation_strings":["Clinical Development, Immunocore Limited, Abingdon-on-Thames, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immunocore Limited, Abingdon-on-Thames, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101816586","display_name":"Christopher J. Holland","orcid":"https://orcid.org/0000-0002-3846-9184","observed_orcids":["https://orcid.org/0000-0002-3846-9184"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Holland","raw_affiliation_strings":["Clinical Development, Immunocore Limited, Abingdon-on-Thames, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immunocore Limited, Abingdon-on-Thames, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064885286","display_name":"Sylwia Marshall","orcid":"https://orcid.org/0000-0001-6596-2786","observed_orcids":["https://orcid.org/0000-0001-6596-2786"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Marshall","raw_affiliation_strings":["Clinical Development, Immunocore Limited, Abingdon-on-Thames, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immunocore Limited, Abingdon-on-Thames, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060489370","display_name":"Sarah Stanhope","orcid":"https://orcid.org/0000-0002-7660-3591","observed_orcids":["https://orcid.org/0000-0002-7660-3591"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Stanhope","raw_affiliation_strings":["Translational Medicine, Immunocore Ltd, Abingdon-on-Thames, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine, Immunocore Ltd, Abingdon-on-Thames, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833504","display_name":"Peter B. Kirk","orcid":"https://orcid.org/0000-0001-8657-2090","observed_orcids":["https://orcid.org/0000-0001-8657-2090"]},"institutions":[{"id":"https://openalex.org/I4210104024","display_name":"Immunocore (United Kingdom)","ror":"https://ror.org/014xzez86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210104024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Kirk","raw_affiliation_strings":["Translational Medicine, Immunocore Ltd, Abingdon-on-Thames, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Medicine, Immunocore Ltd, Abingdon-on-Thames, UK","institution_ids":["https://openalex.org/I4210104024"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064237640","display_name":"Juanita Suzanne Lopez","orcid":"https://orcid.org/0000-0001-8321-4212","observed_orcids":["https://orcid.org/0000-0001-8321-4212"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J.S. Lopez","raw_affiliation_strings":["Drug Development Unit, The Royal Marsden Hospital NHS Foundation Trust, Sutton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, The Royal Marsden Hospital NHS Foundation Trust, Sutton, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":25,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.3994,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.57706478,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":null,"first_page":"S1411","last_page":"S1413"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6122999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6122999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.21699999272823334,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.05090000107884407,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mage-a4","display_name":"MAGE-A4","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.7250000238418579},{"id":"https://openalex.org/keywords/cancer-testis-antigens","display_name":"cancer-testis antigens","score":0.8849999904632568},{"id":"https://openalex.org/keywords/t-cell-redirection","display_name":"T cell redirection","score":0.6919999718666077},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7789999842643738},{"id":"https://openalex.org/keywords/tebentafusp","display_name":"tebentafusp","score":0.8619999885559082},{"id":"https://openalex.org/keywords/metastatic-uveal-melanoma","display_name":"metastatic uveal melanoma","score":0.9369999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7987481355667114},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.783053994178772},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.6288980841636658},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.6175054311752319},{"id":"https://openalex.org/C2776056953","wikidata":"https://www.wikidata.org/wiki/Q1182511","display_name":"De-escalation","level":2,"score":0.5446509718894958},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42049640417099},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.373360276222229},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2734106779098511},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.18052953481674194},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.1551252007484436},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14124393463134766},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13995572924613953},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.13829770684242249},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.067111074924469}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.10.109","doi":"https://doi.org/10.1016/j.annonc.2021.10.109","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.109","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.10.109","doi":"https://doi.org/10.1016/j.annonc.2021.10.109","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.109","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4311146651","https://openalex.org/W3029402008","https://openalex.org/W4295819131","https://openalex.org/W7169805327","https://openalex.org/W4402561053","https://openalex.org/W2748772361","https://openalex.org/W2977825834","https://openalex.org/W4389241965","https://openalex.org/W7162937651","https://openalex.org/W7162578002"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-12-31T00:00:00"}